259 related articles for article (PubMed ID: 2746864)
1. [Flow cytometric DNA measurements of thyroid carcinomas].
Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
[TBL] [Abstract][Full Text] [Related]
2. [Flow cytometric DNA analysis of papillary carcinoma of the thyroid using paraffin-embedded specimens].
Yamashita T; Hirayama A; Obara T; Fujimoto Y; Kodama T; Kenmotsu M; Okuda A
Gan No Rinsho; 1990 Apr; 36(5):569-73. PubMed ID: 2325263
[TBL] [Abstract][Full Text] [Related]
3. [Flow cytometric DNA content analysis in thyroid carcinoma].
Zuo LF
Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):106-9. PubMed ID: 1879287
[TBL] [Abstract][Full Text] [Related]
4. Cytochemical assessments of the nuclear DNA distribution pattern by means of image and flow cytometry in thyroid neoplasms and in non-neoplastic thyroid lesions. A comparative methodological study.
Wallin G; Askensten U; Bäckdahl M; Grimelius L; Lundell G; Auer G
Acta Chir Scand; 1989; 155(4-5):251-8. PubMed ID: 2800873
[TBL] [Abstract][Full Text] [Related]
5. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of cellular DNA content in thyroid tumors by the flow cytometer].
Motomura Y
Nihon Geka Gakkai Zasshi; 1988 Jul; 89(7):1066-74. PubMed ID: 3221827
[TBL] [Abstract][Full Text] [Related]
7. Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma.
Joensuu H; Klemi PJ
Am J Clin Pathol; 1988 Jan; 89(1):35-40. PubMed ID: 3337050
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
[TBL] [Abstract][Full Text] [Related]
9. Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study.
Wallin G; Bäckdahl M; Tallroth-Ekman E; Lundell G; Auer G; Löwhagen T
Eur J Surg Oncol; 1989 Feb; 15(1):43-8. PubMed ID: 2465188
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric DNA analysis of thyroid carcinoma.
Tsuchiya A; Sekikawa K; Ando Y; Suzuki S; Kimijima I; Abe R
Jpn J Surg; 1990 Sep; 20(5):510-4. PubMed ID: 2243443
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic and familial medullary thyroid carcinoma.
Hay ID; Ryan JJ; Grant CS; Bergstralh EJ; van Heerden JA; Goellner JR
Surgery; 1990 Dec; 108(6):972-9; discussion 979-80. PubMed ID: 2247843
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of nuclear DNA content in highly malignant thyroid tumors].
Lukács G; Balázs G; Zs-Nagy I; Juhász F
Wien Klin Wochenschr; 1990 Apr; 102(9):253-6. PubMed ID: 2375112
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of flow cytometric DNA determination combined with fine needle aspiration biopsy in thyroid tumors.
Joensuu H; Klemi PJ; Eerola E
Anal Quant Cytol Histol; 1987 Aug; 9(4):328-34. PubMed ID: 3663313
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
[TBL] [Abstract][Full Text] [Related]
15. [Nuclear DNA content in small thyroid papillary carcinomas determined by microfluorometry].
Omata K; Naoe S; Tanaka N
Gan No Rinsho; 1987 Feb; 33(2):119-24. PubMed ID: 3560446
[TBL] [Abstract][Full Text] [Related]
16. [Nuclear DNA in neoplastic pathology of the thyroid gland].
Sussi PL; Azzolina LS; Valerio A; Marchioretto F; Brazzarola P; Angeli G; Davì MV; Stival P; Finchi A; Francia G
Chir Ital; 1994; 46(5):74-6. PubMed ID: 7788816
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma.
el-Naggar AK; Ordonez NG; McLemore D; Schultz P; Hickey RC; Samaan N
Surgery; 1990 Dec; 108(6):981-5. PubMed ID: 2247844
[TBL] [Abstract][Full Text] [Related]
18. Influence of cellular DNA content on survival in ovarian carcinoma.
Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
[TBL] [Abstract][Full Text] [Related]
19. [The clinical significance of nuclear DNA content measurements in pancreatic neoplasms and their Kaplan-Meier survival analysis].
Sun CY; Zhang YL; Chao SL
Zhonghua Wai Ke Za Zhi; 1994 Jun; 32(6):364-6. PubMed ID: 7842963
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the malignancy in gallbladder cancer assessed by nuclear DNA contents and mitotic indices--with special reference to the prognosis of the patients with cancer involvement to the subserosal layer].
Sato Y; Tanaka J; Yoshioka H; Koyama K
Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):46-51. PubMed ID: 2014025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
